We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Grow Therapy Stock

Invest in or calculate the value of your shares in Grow Therapy or other pre-IPO companies through EquityZen's platform.

Get Started

Grow Therapy Stock (GRTH)

Grow Therapy bridges the gap between therapists and people seeking mental health care to get more people into therapy.

About Grow Therapy Stock

Founded

2020

Headquarters

New York, NY, US

Industries

Health Care

Grow Therapy is on a mission to fundamentally transform mental healthcare accessibility. Grow Therapy empowers therapists to launch and grow thriving in-network private practices. The company is creating game-changing technology to build America’s biggest behavioral healthcare group and ensure that anyone can afford quality mental healthcare. With the mass increase in depression and anxiety from the pandemic, the need for accessibility is more important than ever. To make its vision for mental healthcare a reality, Grow Therapy is building a team of entrepreneurs and mission-driven go-getters. The company's founders come from Harvard Medical School, Stripe, and Blackstone, and are champions of balancing bold ambitions with a culture that promotes holistic well-being. Since launching in 2020, Grow has raised over $15M from top VCs and angel investors, including leaders from SignalFire, Village Global, Airbnb, Nurx, PatientPing, and Blackstone.

Grow Therapy Press Mentions

Stay in the know about the latest news on Grow Therapy

Grow Therapy Management

Leadership team at Grow Therapy

Co-Founder and CTO

Alan Ni

CEO & Co-Founder

Jake Cooper

Locked Features

Join now and verify your accreditation status to gain access to:

  • Grow Therapy current valuation
  • Grow Therapy stock price
  • Available deals in Grow Therapy and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Grow Therapy Stock

How to invest in Grow Therapy stock?

Accredited investors can buy pre-IPO stock in companies like Grow Therapy through EquityZen funds. These investments are made available by existing Grow Therapy shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Grow Therapy stock?

Shareholders can sell their Grow Therapy stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."